HistoSonics announced today that it completed an oversubscribed Series D financing round worth proceeds of $102 million. Alpha Wave Ventures led the round, while new investors Amzak Health and HealthQuest Capital participated. Johnson & Johnson Innovation – JJDC, Venture Investors, Lumira Ventures, Yonjin Venture, the State of Wisconsin Investment Board — all existing investors — […]
histosonics
Histosonics plans expansion in Minnesota
According to a report from CCX Media last week, HistoSonics plans to expand its headquarters in Plymouth, Minnesota. HistoSonics develops a histotripsy treatment for liver tumor procedures. Last year, the FDA granted de novo authorization for its Edison system and novel histotripsy therapy platforms. The report says HistoSonics plans to nearly double the size of its headquarters […]
HistoSonics scores reimbursement win for sonic beam therapy
HistoSonics announced today that the Centers of Medicare & Medicaid Services (CMS) set a new payment rate for its tumor treatment. Minneapolis-based HistoSonics develops a histotripsy treatment for liver tumor procedures. Last month, the FDA granted de novo authorization for its Edison system and novel histotripsy therapy platforms. Edison, an image-guided sonic beam therapy system uses […]
FDA grants de novo nod to HistoSonics histotripsy system
HistoSonics announced today that the FDA granted de novo authorization for its Edison system and novel histotripsy therapy platforms. Edison, an image-guided sonic beam therapy system uses advanced imaging and proprietary sensing technology. It delivers non-invasive, personalized treatments with precision and control. The system received FDA investigational device exemption in February. In March, HistoSonics announced […]
HistoSonics announces first kidney tumor treatment with histotripsy
HistoSonics announced the treatment of the first kidney patient using the company’s histotripsy platform in the United Kingdom. Professor Tze Min Wah, senior consultant radiologist and clinical lead for the interventional oncology program at Leeds Teaching Hospitals NHS Trust, performed the procedure. It marks the initial treatment in HistoSonics’ sponsored “CAIN” trial. The Phase I […]
Medical Alley startups achieve ‘relatively normal’ funding despite pandemic
Medical Alley Association member startups pulled in more than $256 million in funding through June, signaling a “relatively normal” first half of the year 2020 despite the COVID-19 pandemic and battered economy, according to the Minnesota-based trade group. In total, 40 companies raised $256,406,357 in the first 6 months of the year. The $1.75 million median […]
